{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:41:42Z","timestamp":1791632502729,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.eimc.2009.10.002","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T05:00:56Z","timestamp":1264482056000},"page":"122-130","source":"Crossref","is-referenced-by-count":34,"title":["Tetraciclinas, sulfamidas y metronidazol"],"prefix":"10.1016","volume":"28","author":[{"given":"Diego","family":"Vicente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"P\u00e9rez-Trallero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2009.10.002_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0025-7125(16)30039-6","article-title":"Tetracyclines","volume":"79","author":"Klein","year":"1995","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.eimc.2009.10.002_bib2","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archinte.157.13.1421","article-title":"Doxycycline revisited","volume":"157","author":"Joshi","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2009.10.002_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4065\/74.7.727","article-title":"The tetracyclines","volume":"74","author":"Smilack","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.eimc.2009.10.002_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.eimc.2009.10.002_bib5","series-title":"Antibiotic and chemotherapy","first-page":"393","article-title":"Tetracyclines","author":"Chopra","year":"2003"},{"key":"10.1016\/j.eimc.2009.10.002_bib6","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos sanitarios (AEMPS) y Direcci\u00f3n General de Farmacia y Productos Sanitarios (DGFPS). Uso de antibi\u00f3ticos en Espa\u00f1a [consultado 7\/1\/2010]. Disponible en: http:\/\/www.agemed.es\/profHumana\/observatorio\/docs\/Evo_uso_antibioticos96-06.pdf."},{"key":"10.1016\/j.eimc.2009.10.002_bib7","unstructured":"OMS. Medicamentos Esenciales 15 ed. Lista Modelo de la OMS. Marzo 2007 [consultado 7\/1\/2010]. Disponible en: http:\/\/www.who.int\/medicines\/publications\/08_SPANISH_FINAL_EML15.pdf."},{"key":"10.1016\/j.eimc.2009.10.002_bib8","doi-asserted-by":"crossref","first-page":"i11","DOI":"10.1093\/jac\/dkn242","article-title":"Tigecycline pharmacokinetic\/pharmacodynamic update","volume":"62","author":"MacGowan","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.10.002_bib9","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1128\/JCM.00637-08","article-title":"In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest","volume":"46","author":"Pillar","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2009.10.002_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.diagmicrobio.2006.07.005","article-title":"Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study","volume":"56","author":"Betriu","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2009.10.002_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijantimicag.2009.02.003","article-title":"Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004\u20132007)","volume":"34","author":"N\u00f8rskov-Lauritsen","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2009.10.002_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/526775","article-title":"Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline","volume":"46","author":"Anthony","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2009.10.002_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01592-08","article-title":"Emergence of an enterobacter hormaechei with reduced susceptibility to tigecycline under tigecycline therapy","author":"Daurel","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.10.002_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkn165","article-title":"Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: A review of the scientific evidence","volume":"62","author":"Karageorgopoulos","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.10.002_bib15","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1592\/phco.27.8.1198","article-title":"Rapid development of Acinetobacter baumannii resistance to tigecycline","volume":"27","author":"Reid","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.eimc.2009.10.002_bib16","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/AAC.01405-08","article-title":"Tetracycline susceptibility testing and resistance genes in isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex from a US military hospital","volume":"53","author":"Akers","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.10.002_bib17","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1128\/AAC.00695-08","article-title":"In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria","volume":"52","author":"Fern\u00e1ndez-Roblas","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.10.002_bib18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/bmj.38987.606701.80","article-title":"Acne","volume":"333","author":"Purdy","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.eimc.2009.10.002_bib19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3201\/eid0802.01-0521","article-title":"Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax","volume":"8","author":"Bell","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eimc.2009.10.002_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","article-title":"Minocycline and neurodegenerative diseases","volume":"196","author":"Kim","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.eimc.2009.10.002_bib21","first-page":"151","article-title":"Recomendaciones en el tratamiento emp\u00edrico de la infecci\u00f3n intraabdominal","volume":"22","author":"Guirao","year":"2009","journal-title":"Rev Esp Qumiot"},{"key":"10.1016\/j.eimc.2009.10.002_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1054\/drup.2000.0146","article-title":"Sulfonamide resistance: Mechanisms and trends","volume":"3","author":"Skold","year":"2000","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.eimc.2009.10.002_bib23","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/320532","article-title":"Resistance to trimethoprim-sulfamethoxazole","volume":"32","author":"Huovinen","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2009.10.002_bib24","series-title":"Antibiotic and chemotherapy","first-page":"385","article-title":"Sulphonamides","author":"Greenwood","year":"2003"},{"key":"10.1016\/j.eimc.2009.10.002_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archinte.163.4.402","article-title":"Trimethoprim-sulfamethoxazole revisited","volume":"163","author":"Masters","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2009.10.002_bib26","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1128\/AAC.01118-07","article-title":"Connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis","volume":"52","author":"K\u00e4rp\u00e4noja","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.10.002_bib27","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3201\/eid1010.030994","article-title":"Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance","volume":"10","author":"Huang","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eimc.2009.10.002_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/AAC.49.2.741-748.2005","article-title":"Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs","volume":"49","author":"Iliades","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.10.002_bib29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2165\/00003495-199754050-00003","article-title":"Metronidazole. A therapeutic review and update","volume":"54","author":"Freeman","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.eimc.2009.10.002_bib30","first-page":"903","article-title":"Metronidazole","volume":"128","author":"Mart\u00ednez","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.eimc.2009.10.002_bib31","series-title":"Antibiotic and chemotherapy","first-page":"385","article-title":"Nitroimidazoles","author":"Edwards","year":"2003"},{"key":"10.1016\/j.eimc.2009.10.002_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00436-002-0754-9","article-title":"Nitroheterocyclic drugs with broad spectrum activity","volume":"90","author":"Raether","year":"2003","journal-title":"Parasitol Res"},{"key":"10.1016\/j.eimc.2009.10.002_bib33","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/AAC.43.7.1533","article-title":"Why metronidazole is active against both bacteria and parasites","volume":"43","author":"Samuelson","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2009.10.002_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1054\/drup.1999.0104","article-title":"Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa","volume":"2","author":"Land","year":"1999","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.eimc.2009.10.002_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/CMR.14.1.150-164.2001","article-title":"Drug targets and mechanisms of resistance in the anaerobic protozoa","volume":"14","author":"Upcroft","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.eimc.2009.10.002_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jac\/dkp203","article-title":"Overexpression of the rhamnose catabolism regulatory protein, RhaR: A novel mechanism for metronidazole resistance in Bacteroides thetaiotaomicron","volume":"64","author":"Patel","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2009.10.002_bib37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1469-0691.2003.00674.x","article-title":"Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe","volume":"9","author":"Hedberg","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2009.10.002_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijantimicag.2007.11.006","article-title":"European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci","volume":"31","author":"Brazier","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2009.10.002_bib39","doi-asserted-by":"crossref","DOI":"10.1097\/QCO.0b013e32833229ce","article-title":"Clostridium difficile: Controversies and approaches to management","author":"Bauer","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.eimc.2009.10.002_bib40","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2006","volume":"55","author":"Workowski","year":"2006","journal-title":"MMWR Recomm Rep"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X09005187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X09005187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T21:25:34Z","timestamp":1590528334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X09005187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0213005X09005187"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2009.10.002","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}